Heart failure & cardiomyopathies

Short Report: Hospitalization for New-Onset Heart Failure in Survivors of Hospitalized COVID-19

ESC Heart FailPublished prospective cohort study

Authors' conclusion

The incidence of new-onset HF post-COVID-19 in our study was lower than in previous reports, despite involving an older population with more comorbidities and/or more severe COVID-19 overall. Reliance on administrative data for outcome adjudication in prior studies may have led to an overestimation of the HF burden post-COVID-19.

Study context

Population
Survivors of hospitalized COVID-19 free of heart failure (HF) at the time of dischargesurvivors of COVID-19 hospitalization free of HF at discharge
Participants
2,140 survivors
Outcome
Incidence of hospitalized new-onset HF
Follow-up
12-month period following the index COVID-19 episode

Main finding

As reported in the abstract

Incidence rate of hospitalized new-onset HF

0.5 per 100 person-years

Observational data: associations, not effects.

Further findings

Baseline factors associated with HF development

Higher BMI and dialysis dependency at baseline were significantly associated with HF development

1-year mortality

1-year mortality rate
3%

Baseline characteristics

Mean age
67 years
Black/African-Americans
48%

Original publication

Short Report: Hospitalization for New-Onset Heart Failure in Survivors of Hospitalized COVID-19. ESC Heart Fail. Published 5 June 2025. doi:10.1002/ehf2.15331

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.